Funding for this research was provided by:
the Development Center for Medical Science & Technology National Health Commission of the People’s Republic of China (WA2021RW19)
Received: 4 April 2022
Accepted: 11 November 2022
First Online: 22 November 2022
: This trial has been approved by the Ethics Review Committee of the First Hospital of Jilin University (Approval number: 19K135-001). Written informed consent to participate will be obtained from all individuals before screening.
: Not applicable.
: The authors declare that they have no completing interests.